17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells.
about
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicPhase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia.Effects of 17-allylamino-17-demethoxygeldanamycin on the induction of apoptosis and cell cycle arrest in HCT-116 cells.Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status--consequences and potentials for pharmacological intervention.
P2860
17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@ast
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@en
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@nl
type
label
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@ast
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@en
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@nl
prefLabel
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@ast
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@en
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells.
@nl
P2860
P1433
P1476
17-N-Allylamino-17-demethoxyge ...... human acute myelogenous cells
@en
P2093
Jennifer M Napper
P2860
P304
P356
10.1016/J.LEUKRES.2010.05.024
P577
2010-06-19T00:00:00Z